Valuation: Masimo Corporation

Market Cap 9.42B 8.26B 7.61B 7.03B 13.34B 899B 13.56B 90.93B 35.67B 443B 35.38B 34.61B 1,523B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.61B 7.94B 7.34B 13.91B 938B 14.14B 94.86B 37.21B 462B 36.91B 36.1B 1,589B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
3 months+0.91%
6 months+29.53%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 51.1
Extreme 51.1
305.21
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Corporate Officer/Principal 62 01/07/2025
Director TitleAgeSince
Director/Board Member - 10/06/2026
Date Insider Type Main position Quantity % Market Cap.
06-10
Politan Capital Management LP
OthersCompany -273,550 0.5224%
06-10Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
06-10Issuer sale

Director

-3,727 0.0071%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+8.20%+12.74% 9.42B
+0.05%-0.15%+30.44%-2.80% 12.51B
-2.70%-7.53%+56.47%+31.36% 6B
+2.16%-0.14%+7.62%+14.59% 5.73B
+1.59%-1.92% - - 4.23B
+3.82%+5.25%-31.39%+16.08% 4.1B
+1.84%-2.18%-25.21%-27.70% 3.75B
-5.73%-5.23%-11.70%-61.13% 2B
+2.48%+3.12%+20.44%+266.67% 1.89B
-0.98%+0.83%+56.51%-4.27% 1.57B
Average +0.25%+0.25%+12.37%+27.28% 5.12B
Weighted average by Cap. +0.35%-0.14%+15.34%+14.76%

Financials

2024 2025
Net sales 2.09B 1.83B 1.69B 1.56B 2.96B 200B 3.01B 20.21B 7.93B 98.39B 7.86B 7.69B 339B 1.53B 1.34B 1.23B 1.14B 2.16B 146B 2.2B 14.73B 5.78B 71.73B 5.73B 5.61B 247B
Net income -305M -267M -246M -228M -431M -29.08B -439M -2.94B -1.15B -14.32B -1.14B -1.12B -49.29B -152M -133M -122M -113M -214M -14.45B -218M -1.46B -573M -7.12B -569M -556M -24.49B
Net Debt 668M 586M 540M 499M 946M 63.75B 962M 6.45B 2.53B 31.4B 2.51B 2.46B 108B 407M 357M 329M 304M 576M 38.82B 586M 3.93B 1.54B 19.12B 1.53B 1.49B 65.8B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock